Patents by Inventor Raymond C. Bergan

Raymond C. Bergan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of cancer cell motility
    Patent number: 10780076
    Abstract: Provided herein are compositions and methods for inhibiting cancer cell motility and/or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies (e.g., cancer therapies (e.g., hormone therapies and chemotherapies) are provided to inhibit cancer cell motility, inhibit metastasis, and/or treat cancer (e.g., prostate cancer, lung cancer, breast cancer, colon cancer, etc.).
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: September 22, 2020
    Assignee: Northwestern University
    Inventors: Raymond C. Bergan, Karl A. Scheidt, Li Xu
  • INHIBITION OF CANCER CELL MOTILITY
    Publication number: 20190201373
    Abstract: Provided herein are compositions and methods for inhibiting cancer cell motility and/or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies (e.g., cancer therapies (e.g., hormone therapies and chemotherapies) are provided to inhibit cancer cell motility, inhibit metastasis, and/or treat cancer (e.g., prostate cancer, lung cancer, breast cancer, colon cancer, etc.).
    Type: Application
    Filed: March 19, 2019
    Publication date: July 4, 2019
    Inventors: Raymond C. Bergan, Karl A. Scheidt, Li Xu
  • Inhibition of cancer cell motility
    Patent number: 10231949
    Abstract: Provided herein are compositions and methods for inhibiting cancer cell motility and/or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies (e.g., cancer therapies (e.g., hormone therapies and chemotherapies) are provided to inhibit cancer cell motility, inhibit metastasis, and/or treat cancer (e.g., prostate cancer, lung cancer, breast cancer, colon cancer, etc.).
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: March 19, 2019
    Assignee: Northwestern University
    Inventors: Raymond C. Bergan, Karl A. Scheidt, Li Xu
  • INHIBITION OF CANCER CELL MOTILITY
    Publication number: 20180153853
    Abstract: Provided herein are compositions and methods for inhibiting cancer cell motility and/or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies (e.g., cancer therapies (e.g., hormone therapies and chemotherapies) are provided to inhibit cancer cell motility, inhibit metastasis, and/or treat cancer (e.g., prostate cancer, lung cancer, breast cancer, colon cancer, etc.).
    Type: Application
    Filed: December 12, 2017
    Publication date: June 7, 2018
    Inventors: Raymond C. Bergan, Karl A. Scheidt, Li Xu
  • Inhibition of cancer cell motility
    Patent number: 9839625
    Abstract: Provided herein are compositions and methods for inhibiting cancer cell motility and/or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies (e.g., cancer therapies (e.g., hormone therapies and chemotherapies) are provided to inhibit cancer cell motility, inhibit metastasis, and/or treat cancer (e.g., prostate cancer, lung cancer, breast cancer, colon cancer, etc.).
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: December 12, 2017
    Assignee: Northwestern University
    Inventors: Raymond C. Bergan, Karl A. Scheidt, Li Xu
  • INHIBITION OF CANCER CELL MOTILITY
    Publication number: 20160128973
    Abstract: Provided herein are compositions and methods for inhibiting cancer cell motility and/or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies (e.g., cancer therapies (e.g., hormone therapies and chemotherapies) are provided to inhibit cancer cell motility, inhibit metastasis, and/or treat cancer (e.g., prostate cancer, lung cancer, breast cancer, colon cancer, etc.).
    Type: Application
    Filed: November 6, 2015
    Publication date: May 12, 2016
    Inventors: Raymond C. Bergan, Karl A. Scheidt, Li Xu
  • Inhibition and treatment of prostate cancer metastasis
    Patent number: 8742141
    Abstract: The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: June 3, 2014
    Assignee: Northwestern University
    Inventors: Raymond C. Bergan, Karl A. Scheidt
  • INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS
    Publication number: 20130296582
    Abstract: The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
    Type: Application
    Filed: July 1, 2013
    Publication date: November 7, 2013
    Inventors: Raymond C. Bergan, Karl A. Scheidt
  • Inhibition and treatment of prostate cancer metastasis
    Patent number: 8481760
    Abstract: The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: July 9, 2013
    Assignee: Northwestern University
    Inventors: Raymond C. Bergan, Karl A. Scheidt
  • INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS
    Publication number: 20120283313
    Abstract: The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
    Type: Application
    Filed: July 23, 2012
    Publication date: November 8, 2012
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Raymond C. Bergan, Karl A. Scheidt
  • INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS
    Publication number: 20100137425
    Abstract: The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
    Type: Application
    Filed: October 13, 2009
    Publication date: June 3, 2010
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Raymond C. Bergan, Karl A. Scheidt
  • INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS
    Publication number: 20090124569
    Abstract: The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
    Type: Application
    Filed: October 13, 2008
    Publication date: May 14, 2009
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Raymond C. Bergan, Karl A. Scheidt